Empowering consumers: Tools for understanding medicines governance webinar
Effective medicines governance safeguards consumers use of medicines within the hospital system. However, medicines governance is a complex area for…
Navigating high-cost medicines: summary of the Guiding Principles for the governance of high-cost medicines in Australian hospitals
Navigating high-cost medicines: summary of the Guiding Principles for the governance of high-cost medicines in Australian hospitals Catherine L. Hill,…
Medicines Stewardship webinar
This webinar explores the concept of medicine stewardship, emphasising the importance of safe and quality use of medicines and its…
Navigating High-Cost Medicines
Promoting consistent, evidence based use of high cost medicines in a fiscally and equitable responsible manner. Presented at Health Technology…
Partnership model to address misconceptions and optimise first-line therapy for rheumatoid arthritis
Presented as an oral presentation at the National Medicines Symposium 2022
Translating evidence into practice through evidence-based resources for the management of Inflammatory Bowel Disease
Poster presentation for SHPA Medicines Management 2021 conference Objective: To identify knowledge gaps of health professionals around biologic treatment for inflammatory…
Engaging Clinicians and Consumers in the design and implementation of a National Education Program for Inflammatory Arthritis
Poster presentation at ARA Annual Scientific Meeting May 2022
Designing a National Education Program to support quality use of medicines in Inflammatory Bowel Disease
The program aims to achieve better patient health outcomes, support optimal use of biological and small molecule medicines and contribute…
What do Rheumatologists think and do in the management of Inflammatory Arthritis: A Baseline Survey
Presented at ARA Annual Scientific Meeting May 2021
Patterns of use of b/tsDMARDS and other medications for with Rheumatoid Arthritis: a retrospective study using PBS data
Presented at ARA Annual Scientific Meeting May 2021 Aims to describe prescribing patterns for biological/targeted synthetic disease-modifying antirheumatic drugs (b/tsDMARDs)…